有機化學人才網 | 最新人才 | 最新職位 | 技術交易 | 藥物合成 |
   
全站搜索: |
  您當前位置:網站首頁 >> 藥物合成路線圖解
 

藥物詳細合成路線

Name Rofecoxib;MK-966;MK-0966;Vioxx
Chemical Name 4-[4-(Methylsulfonyl)phenyl]-3-phenylfuran-2(5H)-one
CAS 162011-90-7
Related CAS
Formula C17H14O4S
Structure
Formula Weight 314.36273
Stage 撤市-2004
Company Banyu (Originator), Merck & Co. (Originator), Merck Frosst (Originator), CollaGenex (Comarketer)
Activity/Mechanism Acute Attacks of Migraine, Treatment of, Alzheimers Dementia, Treatment of , ANALGESIC AND ANESTHETIC DRUGS, Analgesic Drugs, Antiarthritic Drugs, Antimigraine Drugs, Cognition Disorders, Treatment of, Colorectal Cancer Therapy, Dental Agents, ENDOCRINE DRUGS, Gynecological Disorders, Treatment of , NEUROLOGIC DRUGS, Non-Opioid Analgesics, Oncolytic Drugs, Osteoarthritis, Treatment of, Rheumatoid Arthritis, Treatment of, Treatment of Dysmenorrhea, TREATMENT OF MUSCULOSKELETAL & CONNECTIVE TISSUE DISEASES, Cyclooxygenase-2 Inhibitors
Syn. Route 5
Route 1
the synthesis of rofecoxib can be performed by several different ways:1) the condensation of phenylacetic acid (i) with ethyl bromoacetate (ii) by means of triethylamine in thf yields 2-(phenylacetoxy)acetic acid ethyl ester (iii), which is cyclized to the hydroxyfuranone (iv) by means of potassium tert-butoxide in tert-butanol. the reaction of (iv) with triflic anhydride and diisopropylethylamine in dichloro-methane affords the corresponding triflate (v), which by reaction with libr in hot acetone yields the bromofuranone (vi). the condensation of (vi) with 4-(methylsulfanyl)phenylboronic acid (vii) by means of na2co3 and pd(ph3p)4 in hot toluene gives 4-[4-(methylsulfanyl)-phenyl]-3-phenylfuran-2(5h)-one (viii), which is finally oxidized with 2khso5.khso4.k2so4 (oxone).2) the intermediate (viii) can also be obtained by condensation of triflate (v) with boronic acid (vii) by means of na2co3 and pd(ph3p)4 in hot toluene.3) the intermediate (viii) can also be synthesized by the reaction of triflate (v) with tetramethylammonium chloride, giving the chlorofuranone (ix), which is then condensed with boronic acid (vii) as before.
List of intermediates No.
methyl 3-hydroxy-5-iodobenzoate (i)
[(2r,3s,4s,5r)-5-(6-amino-2-fluoro-9h-purin-9-yl)-3,4-dihydroxytetrahydro-2-furanyl]methyl diethyl phosphate (ii)
2-methoxy-5-[(methylimino)methyl]phenol (vii)
5-([4-[(2s)-4-hydroxy-2-methyltetrahydro-2h-pyran-4-yl]-2-thienyl]sulfanyl)-1-methyl-1,3-dihydro-2h-indol-2-one (iii)
(2s)-2-methyl-4-(5-sulfanyl-3-thienyl)tetrahydro-2h-pyran-4-ol (iv)
5-bromo-1-methyl-1,3-dihydro-2h-indol-2-one (v)
methyl 3-[[6-(benzyloxy)-4-oxo-2h-chromen-3(4h)-ylidene]methyl]-4-hydroxybenzoate (vi)
(3r,4r)-3-(5-amino-2-methoxybenzyl)-6-[(5,6-difluoro-1,3-benzothiazol-2-yl)methoxy]-3,4-dihydro-2h-chromen-4-ol (viii)
5-bromo-3-thiophenecarbaldehyde (ix)
Reference 1:
    sorbera, l.a.; rabasseda, x.; casta?er, j.; rofecoxib. drugs fut 1998, 23, 12, 1287.
Reference 2:
    tillyer, r.; desmond, r.; dolling, u.; marcune, b.; tschaen, d. (merck & co., inc.); process for making phenyl heterocycles useful as cox-2 inhibitors. wo 9608482 .

Route 2
4) the oxidation of 4-(methylsulfanyl)acetophenone (x) with monoperoxyphthalic acid (mmpp) in dichloro-methane/methanol gives the corresponding sulfone (xi), which is brominated with br2/alcl3 in chloroform, yielding the expected phenacyl bromide (xii). finally, this compound is cyclocondensed with phenylacetic acid (i) by means of 1,8-diazabicyclo[5.4.0]undec-7-ene (dbu) and triethylamine in acetonitrile.5) reaction of [4-(methylsulfonyl)phenyl]phenylacetyl-ene (xiii) with co catalyzed by rh4(co)12 in thf at 100 c in a stainless steel autoclave at 100 atm pressure, followed by a chromatographic separation in a silicagel column to eliminate the undesired regioisomer.
List of intermediates No.
methyl 3-hydroxy-5-iodobenzoate (i)
(5-bromo-3-thienyl)methanol (x)
4-(hydroxymethyl)-2-thiophenecarbonitrile (xi)
4-(bromomethyl)-2-thiophenecarbonitrile (xii)
tert-butyl (3s)-1-[(5-cyano-3-thienyl)methyl]-2-oxopyrrolidinylcarbamate (xiii)
Reference 1:
    sorbera, l.a.; rabasseda, x.; casta?er, j.; rofecoxib. drugs fut 1998, 23, 12, 1287.
Reference 2:
    atkinson, j.g.; wang, z. (merck frosst canada inc.); stilbene derivs. useful as cyclooxygenase-2 inhibitors. ep 0788476; jp 1998507765; wo 9613483 .
Reference 3:
    ducharme, y.; gauthier, j.y.; prasit, p.; leblanc, y.; wang, z.; leger, s.; therien, m. (merck frosst canada inc.); phenyl heterocycles as cyclooxygenase-2 inhibitors. ep 0705254; ep 0739340; ep 0754687; ep 0822190; ep 0980866; jp 1997500372; jp 1997506631; jp 2000038375; us 5474995; wo 9500501; wo 9518799 .
Reference 4:
    hancock, b.; winters, c.; gertz, b.; ehrich, e. (merck & co., inc.; merck frosst canada inc.); compsns. for a once a day treatment of cyclooxygenase-2 mediated diseases. jp 1999512754; wo 9744028 .

Route 3
6) the reaction of 4-bromothioanisole (xiv) with furan-2(5h)-one (xv) by means of tert-buli/cui in ethyl ether, followed by silylation with trimethylsilyl chloride gives 4-[4-(methylsulfanyl)phenyl]-2-(trimethylsilyloxy)-3,4-dihydrofuran (xvi), which is desilylated with palladium acetate in acetonitrile to afford the furanone (xvii). the iodination of (xvii) with i2 in pyridine yields 3-iodo-4-[4-(methylsulfanyl)phenyl]furan-2(5h)-one (xviii), which is condensed with phenylboronic acid (xix) by means of triphenylarsine and a pd catalyst in refluxing benzene, giving 4-[4-(methylsulfanyl)phenyl]-3-phenylfuran-2(5h)-one (viii), already described in scheme 1. finally, this compound is oxidized with monoperoxyphthalic acid magnesium salt in dichloromethane/methanol.
List of intermediates No.
(4ar,6r,7r,7as)-6-(6-amino-9h-purin-9-yl)-2,7-dihydroxytetrahydro-4h-2lambda(5)-furo[3,2-d][1,3,2]dioxaphosphinin-2-one (xix)
(3r,4r)-3-(5-amino-2-methoxybenzyl)-6-[(5,6-difluoro-1,3-benzothiazol-2-yl)methoxy]-3,4-dihydro-2h-chromen-4-ol (viii)
4-[[(3s)-3-amino-2-oxopyrrolidinyl]methyl]-2-thiophenecarbonitrile (xiv)
7-methoxy-2-naphthalenesulfonyl chloride (xv)
n-[(3s)-1-[(5-cyano-3-thienyl)methyl]-2-oxopyrrolidinyl]-7-methoxy-2-naphthalenesulfonamide (xvi)
n-[(3s)-1-[(5-cyano-3-thienyl)methyl]-2-oxopyrrolidinyl]-7-methoxy-n-methyl-2-naphthalenesulfonamide (xvii)
4-[4-hydroxy-1-(4-hydroxyphenyl)-1-methyl-4,4-diphenylbutyl]phenol (xviii)
Reference 1:
    sorbera, l.a.; rabasseda, x.; casta?er, j.; rofecoxib. drugs fut 1998, 23, 12, 1287.
Reference 2:
    atkinson, j.g.; wang, z. (merck frosst canada inc.); stilbene derivs. useful as cyclooxygenase-2 inhibitors. ep 0788476; jp 1998507765; wo 9613483 .
Reference 3:
    hancock, b.; winters, c.; gertz, b.; ehrich, e. (merck & co., inc.; merck frosst canada inc.); compsns. for a once a day treatment of cyclooxygenase-2 mediated diseases. jp 1999512754; wo 9744028 .

Route 4
7) the friedel-crafts condensation of thioanisole (xx) with acetyl chloride (xxi) by means of alcl3 in dichlorobenzene gives the corresponding acetophenone (x), which is oxidized with h2o2/wo4na2 to the ketosulfone (xi). the bromination of (xi) with br2 in acetic acid/48% hbr affords the phenacyl bromide (xii), which is condensed with phenylacetic acid sodium salt (xxiii) in dmf, giving the phenacyl ester (xxii). finally, this compound is cyclized by means of diisopropylamine in dmf.
List of intermediates No.
(5-bromo-3-thienyl)methanol (x)
4-(hydroxymethyl)-2-thiophenecarbonitrile (xi)
4-(bromomethyl)-2-thiophenecarbonitrile (xii)
2-hydroxy-5-iodobenzaldehyde (xx)
5-iodo-2-[(2-methoxyethoxy)methoxy]benzaldehyde; 5-iodo-2-[(2-methoxyethoxy)methoxy]benzaldehyde (xxi)
[5-iodo-2-[(2-methoxyethoxy)methoxy]phenyl]methanol (xxii)
2-[[2-(bromomethyl)-4-iodophenoxy]methoxy]ethyl methyl ether; 2-(bromomethyl)-4-iodo-1-[(2-methoxyethoxy)methoxy]benzene (xxiii)
Reference 1:
    sorbera, l.a.; rabasseda, x.; casta?er, j.; rofecoxib. drugs fut 1998, 23, 12, 1287.
Reference 2:
    frey, l.f.; dolling, u.h.; desmond, r.; tillyer, r.d.; tschaen, d.m. (merck & co., inc.); process of preparing phenyl heterocycles useful as cox-2 inhibitors. wo 9800416 .

Route 5
the friedel crafts acylation of thioanisole (i) with acetyl chloride (ii) and alcl3 in chloroform gives 4-(methylsulfanyl)acetophenone (iii), which is oxidized with monoperoxyphthalic acid (mmpp) in methanol/dichloromethane to yield 4-(methylsulfonyl)acetophenone (iv). the bromination of (iv) with br2 and alcl3 in chloroform affords 4-(methylsulfonyl)phenacyl bromide (v), which is finally cyclized by means of dbu and tea in acetonitrile to provide the target furanone derivative.
List of intermediates No.
methyl 3-hydroxy-5-iodobenzoate (vi)
(5-bromo-3-thienyl)methanol (iii)
4-(hydroxymethyl)-2-thiophenecarbonitrile (iv)
4-(bromomethyl)-2-thiophenecarbonitrile (v)
2-hydroxy-5-iodobenzaldehyde (i)
5-iodo-2-[(2-methoxyethoxy)methoxy]benzaldehyde; 5-iodo-2-[(2-methoxyethoxy)methoxy]benzaldehyde (ii)
Reference 1:
    thérien, m.; gauthier, j.y.; leblanc, y.; leger, s.; perrier, h.; prasit, p.; wang, z.; synthesis of rofecoxib, (mk 0966, vioxx(r)) 4-(4-methylsulfonylphenyl)-3-phenyl-2(5h)-furanone), a selective and orally active inhibitor of cyclooxygenase-2. synthesis (stuttgart) 2001, 12, 1778.

來源:藥化網

作者:藥化小編

摘要:本文合成路線介紹的是藥物中文名羅非昔布;英文名Rofecoxib;MK-966;MK-0966;Vioxx;CAS[162011-90-7]

 
推薦VIP企業
無錫景耀生物科技有限公司
杭州盧普生物科技有限公司
寧波賽倫化工有限公司
蘇州昊賽生物科技有限公司
北京嘉盛揚醫藥科技有限公司
上海澤涵生物醫藥科技有限公司
河北固安三利化工公司
鄭州凱普瑞生物技術有限公司
上海藥谷藥業有限公司
蘭州康寓信生物科技有限公司
湖北朗昕生化藥業有限公司
武漢福鑫化工有限公司
嘉興市英南化工有限公司
蘇州迪飛醫藥科技有限公司
唐山盛源澤興化工有限公司
上海盛中醫藥化工有限公司
連云港天和化學有限公司
南京晨瑞醫藥科技有限公司
南京蘇如化工有限公司
常州瑞盛化工有限公司
熱門文章
505(b)(2)+孤兒藥:氫
北京市農林科學院質標中心在農藥
由內剖析行業發展需求,向外放眼
醫用活性成分——茶樹油在國內農
河南首批19家化工類產業集聚區
安道麥收購巴拉圭重要農資經銷商
澤布替尼:百濟神州BTKi銷售
廣西匯豐新工廠竣工投產,年產農
豐山集團擬投資16.30億元建
瑞士宣布將禁止出口已被禁用的百
巴斯夫擬關閉位于美國和德國的兩
國家藥品集采醫保資金結余留用資
美國環境保護署提議批準拜耳的四
河南星火農業擬投建毒死蜱、硝磺
118家農藥企業被列為2020
春季角結膜炎缺乏長效藥物 境外
重磅!農藥廣告審查發布新規定,
這個藥被稱為萬能藥,專治各種疑
中國農科院植保所成功解析新煙堿
防治小麥赤霉病——國內產品登記
 友情鏈接
有機化學人才網  
首頁 | 廣告服務 | 建站服務 | 關于我們 | 聯系我們 | 版權聲明
丹佛掘金vs 电子游艺注册送彩金 中国体彩比分直播 最大的骗局泰达币 体彩22选5预测工作室 足彩半全场大赢家3.08 新疆11选5前三走势图 比特币暴涨了多少倍 街机金蟾捕鱼下载安装 武汉麻将多少张牌 彩票中奖重复号码查询 15日世界杯比分 理财软件排行 麻将三国大富翁内购版 湛江七星彩头尾app 半全场胜负怎样算中奖 cba季后赛大比分